dortadil

Dorticil is a medication used primarily to treat hypertension, which is a condition characterized by elevated blood pressure. It is a drug in the class of calcium channel blockers, specifically a dihydropyridine compound.

When taken orally, Dorticil is absorbed into the bloodstream and exerts its pharmacological effects by blocking calcium channels in the smooth muscle cells of the blood vessels, particularly the arterioles. This action results in vasodilation, or the widening of the blood vessels, which reduces the resistance to blood flow and subsequently lowers the blood pressure.

The therapeutic effects of Dorticil are typically seen within 1-2 hours after oral administration, and its effects can last for several hours. The drug is available in various formulations and concentrations, including immediate-release and extended-release tablets and capsules.

Common side effects of Dorticil include dizziness, headache, fatigue, and edema. Rare but serious side effects include hypotension (low blood pressure), which can be exacerbated by other medications, especially those that lower blood pressure or expand blood vessels. Patients taking Dorticil should be aware of these potential risks and inform their healthcare provider of any adverse effects.

In clinical trials, Dorticil has been shown to be effective in reducing blood pressure and improving cardiac outcomes in patients with hypertension. It has been used to treat a variety of other cardiovascular conditions, including angina pectoris and coronary artery disease.